[PSTX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
09-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -147.32%
YoY- -3,331,900.00%
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 9,352 20,013 10,343 9,921 116,306 2,700 1,435 248.50%
PBT -31,671 -27,456 -38,847 -33,026 70,661 -43,036 -58,057 -33.21%
Tax -107 4,681 1,359 292 252 1,491 1,096 -
NP -31,778 -27,456 -40,206 -33,318 70,409 -44,527 -59,153 -33.89%
Tax Rate - - - - -0.36% - - -
Total Cost 41,130 47,469 50,549 43,239 45,897 47,227 60,588 -22.74%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -339.80 -137.19 -388.73 -335.85 60.54 -1,649.15 -4,122.16 -81.03%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.35 -0.32 -0.47 -0.39 0.92 -0.71 -0.95 -48.57%
EPS Diluted -0.35 -0.32 -0.47 -0.39 0.92 -0.71 -0.95 -48.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.